Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action

This publication has 12 references indexed in Scilit:

• The Challenge of Treating Children With Hepatitis C Virus Infection
  Journal of Pediatric Gastroenterology and Nutrition, 2017
• Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations
  Clinical Infectious Diseases, 2017
• Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients
  Pediatric Drugs, 2017
• Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025
  PLOS ONE, 2016
• Global burden of drug-resistant tuberculosis in children: a mathematical modelling study
  The Lancet Infectious Diseases, 2016
• Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis
  Clinical Infectious Diseases, 2016
• Optimizing drugs to reach treatment targets for children and adolescents living with HIV
  Journal of the International AIDS Society, 2015
• The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children
  BMC Pediatrics, 2010
• Pediatric Tuberculosis: Global Overview and Challenges
  Clinical Infectious Diseases, 2010
• Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
  New England Journal of Medicine, 2003